This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
Positive opinions based on significant survival benefit
UHI is envisioned as a foundational layer of the Ayushman Bharat Digital Mission and aims to enable interoperability in health services in India through open protocols
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Ayúdame3D has become a leading social entity in social technology.
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Company to open new headquarters in 2024
Subscribe To Our Newsletter & Stay Updated
